Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets

_{Search stocks}

IND

IND

Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding

Research Reports published by BOB CAPITAL MARKETS LTD.

Latest research reports published by BOB Capital Markets Ltd.

Table view

Equitas Small Finance Bank Ltd.

28 Mar 2025

57.65

1.77%

[Initiation] Equitas Small Finance Bank: De-risked portfolio growth; available at a discount

buy

Buy: Equitas Small Finance Bank...

by BOB Capital Markets Ltd.

Target: 73 | Upside : 26.6%

BOB Capital Markets Ltd.

Rising share of diversified and secured portfolio with MFI mix likely to decline further; scaling up granular deposit franchise

Copy LinkShare on

Share on Share on Share on

Alert

Equitas Small Financ.. has an average target of 85.67 from 6 brokers.

Suven Pharmaceuticals Ltd.

24 Mar 2025

1149.60

8.59%

[Initiation] A play on the ADC growth segment

buy

Buy: Suven Pharmaceuticals Ltd.

by BOB Capital Markets Ltd.

Target: 1405 | Upside : 22.2%

BOB Capital Markets Ltd.

ADC is an evolving second line of treatment in oncology. The company expects market size to grow to US$ 50bn by FY33 from US$ 5bn in FY22

Copy LinkShare on

Share on Share on Share on

Alert

Suven Pharmaceuticals Ltd.'s price crossed above 30Day SMA today

Software & Services

SECTOR | 21 Mar 2025

Accenture (NOT RATED): Significant deceleration on the cards. Unsure if worst is over

buy

Software & Services

by BOB Capital Markets Ltd.

BOB Capital Markets Ltd.

YoY organic growth is expected to decelerate from ~4.5% in 2QFY25 to 0.5% in 4Q. Implies a US$2.6bn annualized organic revenue loss

Copy LinkShare on

Share on Share on Share on

Alert

KRChoksey released a Sector Update report for Software & Services on 27 Mar, 2025.

Aurobindo Pharma Ltd.

17 Mar 2025 US FDA Observation US FDA Approval

1082.45

2.31%

Aurobindo Pharma (BUY): Growth triggers intact; valuations attractive

buy

Buy: Aurobindo Pharma Ltd.

by BOB Capital Markets Ltd.

Target: 1451 | Upside : 34.0%

Recommendation Target

BOB Capital Markets Ltd.

Eugia unit 3 capacity utilization to increase to 60-65% from 50% in Q3FY25. We expect capacity utilisation to rise above 70% in FY26E

Copy LinkShare on

Share on Share on Share on

Alert

Number of FII/FPI investors decreased from 746 to 730 in Dec 2024 qtr

IndusInd Bank Ltd.

11 Mar 2025

689.50

1.61%

IndusInd Bank (HOLD): Net worth impact led by accounting discrepancy; HOLD

buy

Hold: IndusInd Bank Ltd.

by BOB Capital Markets Ltd.

Target: 870 | Upside : 26.2%

Recommendation Target

BOB Capital Markets Ltd.

Discrepancy in derivative portfolio account to adversely impact net worth by 2.35%, indicates weak internal controls

Copy LinkShare on

Share on Share on Share on

Alert

IndusInd Bank Ltd. has lost -55.68% in the last 1 Year

Supreme Industries Ltd.

11 Mar 2025

3168.50

1.12%

Supreme Industries (BUY): Wavin acquisition to bolster SI's market share and return ratios

buy

Buy: Supreme Industries Ltd.

by BOB Capital Markets Ltd.

Target: 5150 | Upside : 62.5%

Target

BOB Capital Markets Ltd.

Wavin acquisition will enable SI to gain market share in North and South India

Copy LinkShare on

Share on Share on Share on

Alert

Supreme Industries Ltd. is trading below all available SMAs

Sun Pharmaceutical Industries Ltd.

10 Mar 2025

1687.55

2.14%

Sun Pharma (BUY): Acquiring Checkpoint Therapeutic to widen Specialty portfolio

buy

Buy: Sun Pharmaceutical Industr...

by BOB Capital Markets Ltd.

Target: 2086 | Upside : 23.6%

BOB Capital Markets Ltd.

SUNP to acquire Checkpoint Therapeutic for US$ 4.10 a share, at ~66% premium to its last closing price. Deal valued at US$ 355mn

Copy LinkShare on

Share on Share on Share on

Alert

Promoters unpledged 0.10% of shares in last quarter. Total pledge stands at 0.69% of promoter holdings

UltraTech Cement Ltd.

01 Mar 2025

11502.65

0.93%

Ultratech Cement (BUY): Diversification Play; Sharp focus on Cement Stays, Retain BUY

buy

Buy: UltraTech Cement Ltd.

by BOB Capital Markets Ltd.

Target: 13137 | Upside : 14.2%

BOB Capital Markets Ltd.

UTCEM allocates Rs18bn (~2% of capital allocation) in the building material value chain by investing in wire and cable business

Copy LinkShare on

Share on Share on Share on

Alert

UltraTech Cement Ltd. has an average target of 12844.09 from 12 brokers.

Federal Bank Ltd.

24 Feb 2025

190.44

0.25%

Federal Bank (BUY): Unfolding strategy, implementation remains the key

buy

Buy: Federal Bank Ltd.

by BOB Capital Markets Ltd.

Target: 236 | Upside : 23.9%

Target

BOB Capital Markets Ltd.

FB plans to grow advances 1.5x nominal GDP growth in the next three years

Copy LinkShare on

Share on Share on Share on

Alert

Federal Bank Ltd. is trading below its 100 day SMA of 193.4

Hindware Home Innovation Ltd.

17 Feb 2025

197.51

0.24%

Hindware Home Innovation (BUY): Another disappointing quarter on muted demand

buy

Buy: Hindware Home Innovation Ltd.

by BOB Capital Markets Ltd.

Target: 250 | Upside : 26.6%

Target

BOB Capital Markets Ltd.

Dismal Q3 on weak performance across segments due to muted demand environment

Copy LinkShare on

Share on Share on Share on

Alert

Hindware Home Innovation Ltd. has lost -36.06% in the last 6 Months

loading

Trendlyne

Stay ahead of the market

Company

Privacy Disclaimer Terms of Use Contact Us

Resources

Blog FAQs Stock Market Widgets

Copyright © 2025 Giskard Datatech Pvt Ltd